Category Archives: Health

What is new in the field of Health. Trending topics, and cutting edge research in the are of Health. Press Releases that give us updates on Health.

BT-1 touchless body temperature screening station from Applied Concepts / Stalker Radar meets BAA guidelines for governments and other public organizations


BT-1 automatic body temperature screening station.

BT-1 automatic body temperature screening station.

The individual to be screened simply faces the monitor and holds still for a few seconds during the scan.

Automatic, touchless temperature scanning makes the BT-1 automatic body temperature screening station from Applied Concepts, Inc. / Stalker Radar the perfect choice for federal, state, and local governments, as well as other public organizations with Buy American mandates.

As more and more people return to the workplace, government offices, restaurants, schools, sporting venues, and other public spaces, proactive COVID-19 screening measures have become the rule rather than the exception. One of the most effective is taking a person’s temperature.

On premise temperature scanning shows employees that their health concerns are taken seriously.

The BT-1’s 10-second scan time excels at screening groups efficiently and accurately. The individual to be screened simply faces the monitor and holds still for a few seconds during the scan. If their temperature is in the normal range, a confirmation label is printed. If their temperature is outside the preset normal range, an audible alert message is sent.

The BT-1 is a free-standing system that requires no assembly aside from connecting a few cables.

Either Fahrenheit or Centigrade can be programmed in the system configuration. The BT-1 provides verbal cues to guide the person into the right position for temperature measurement.

The BT-1 can communicate through an Ethernet or wireless Wi-Fi network and can be set to send emails when readings are over the temperature measurement threshold.

The BT-1 can download its settings through one of its three USB ports. The settings can then be copied into as many BT-1s as desired for consistent unit-to-unit parameters.

Municipal, state, and county Governments, schools, professional sports teams, and manufacturers around the globe requiring state-of-the-art measurement applications look to Applied Concepts / Stalker Radar products for the utmost in quality and value. These devices are manufactured in our Texas facility and meet the Buy America Act, allowing federal grant money to be used to purchase these products.

The BT-1 is designed to perform the function of measuring body temperature in non-clinical settings.

Share article on social media or email:

LM Medical NYC is proud to announce the launch of their new comprehensive website


News Image

Our revamped website serves as a great resource for individuals to learn more about the many treatment options we offer in dermatology and facial plastic surgery, says Dr. Lesley Rabach

LM Medical NYC’s fully redesigned website, http://www.lmmedicalnyc.com, features detailed information regarding the wide range of dermatologic and facial plastic surgery options available at the unique medical practice. At LM Medical NYC, patients receive the benefit of access to two top physicians in their respective medical fields, all at one state-of-the-art facility. As sisters and founders of the practice, Dr. Lesley Rabach, a board-certified facial plastic surgeon, and Dr. Morgan Rabach, a board-certified dermatologist, come together to provide the highest-quality medical, surgical and cosmetic care for patients. On the newly designed website, visitors can learn more about LM Medical NYC and the latest in clinical dermatology treatments for skin concerns and cosmetic plastic surgery options. Combining expertise in facial plastic surgery and dermatology, the practice provides a customized approach to meet each patient’s personal needs in a state-of-the-art clinic. LM Medical NYC has created a comfortable, upscale atmosphere for patients seeking services, ranging from non-invasive cosmetic injections to a youthful makeover with facelift surgery.

“Our revamped website serves as a great resource for individuals to learn more about the many treatment options we offer in dermatology and facial plastic surgery,” says Dr. Lesley Rabach

More about LM Medical NYC:

LM Medical NYC offers expertise in two fields of medicine to help patients achieve the appearance they desire at their clinic on 5th Avenue in Manhattan. Dr. Lesley Rabach is Yale-trained, and double board-certified in Otolaryngology and Facial Plastic Surgery, with a stellar reputation for creating natural, exquisite results for patients. Her extensive education, training and experience have earned accolades in her field, and Dr. Lesley has been published in various medical journals. Dr. Morgan Rabach is a board-certified dermatologist who also has been recognized for her many accomplishments in dermatology and aesthetics. She has received many top rankings in her field and has a substantial media presence in some of the top beauty publications around the world.

LM Medical NYC’s clinic is located at 33 Fifth Avenue #1B in New York, NY, and offers cutting-edge cosmetic surgery and skin care treatments. For more information or to schedule a consultation or appointment, please call 212-777-2272, or visit http://www.lmmedicalnyc.com.

Share article on social media or email:

Barbara Littman House Welcomes Mother & Children, Survivors of Domestic Violence, into Newly Renovated, Historic Home


Ribbon Cutting Ceremony Barbara Littman House (L to R) John Keller, president of Town Clock CDC, Leonard Littman, sponsored house in memory of wife, Susan Kramer-Mills, executive director of Town Clock CDC

Ribbon Cutting Ceremony Barbara Littman House (L to R) John Keller, president of Town Clock CDC, Leonard Littman, sponsored house in memory of wife, Susan Kramer-Mills, executive director of Town Cloc

“It was important to Barbara that battered women and their children have a safe place to go for help,” says Leonard Littman,

During National Domestic Violence Awareness Month, Town Clock Community Development Corporation welcomes a mother and her three children into a safe, permanent home. Formerly the sexton house for the First Reformed Church of New Brunswick, this newly renovated historic home allows Town Clock CDC to fulfill its mission to provide sanctuary for an entire family. Dedicated as the Barbara Littman House, this is the organization’s first expansion since 2016 when it opened Dina’s Dwellings, a facility of 10 supportive, affordable, permanent, housing units for survivors.

“Dina’s Dwellings was a special cause for Barbara near the end of her life. She had been helping causes for battered women in Jerusalem when we learned about Town Clock from the wife of a high school friend. It was important to Barbara that battered women and their children have a safe place to go for help,” says Leonard Littman, who was married for 53 years to Barbara, a devoted mother of three, grandmother of 10, design pioneer, teacher, professor and passionate philanthropist.

“Barbara would have been honored to know this house was named for her. She loved children and started her career as a kindergarten teacher in the Head Start Program. Barbara would be very happy to know she is still helping children,” says Littman who points out that Barbara became an accomplished ASID and award-winning interior designer whose work was in many publications including House and Garden and Home Beautiful. In her 50s, she got a masters degree in architecture and worked in that field. Video highlights of ribbon-cutting ceremony.

“We did well in life and believe you have to give back to the community. We wanted to help locally, where we got our start in business,” says Littman, whose father opened the original Littman Jewelers in New Brunswick in 1934. “To me, Barbara was the finest person I ever met in my life. She loved everyone and everyone loved her. She was beautiful inside and out.”

According to Town Clock CDC Executive Director Reverend Susan Kramer Mills, “We are extremely grateful to Leonard for his support and continuing Barbara’s legacy of helping survivors of domestic violence. We are so proud and honored to be able to remember such a wonderful woman in a way that is especially meaningful to her, her family and our community.”

The Barbara Littman House was made possible by grants from the New Brunswick HOME Housing and Urban Development Fund and the Middlesex County Housing First Capital Grant. It also was made possible because of private donations from Leonard Littman, Judith Johnson and Bruce Bush, Christine and Benjamin Bucca, and the Domestic Violence Response Team, Woodbridge. In-kind support was provided by Jennifer Ganley, Architect, PS&S; Elizabeth Garlatti, and Three L & Co.

Domestic Violence

According to the National Domestic Violence Hotline, domestic violence is a pattern of behaviors used by one partner to maintain power and control over another partner in an intimate relationship. It can include physical and sexual violence, psychological abuse and financial control. The National Coalition Against Domestic Violence finds that 57% of homeless women cite Domestic Violence as cause of their homelessness, and 33% of women have experienced domestic violence in their lifetime. The Childhood Domestic Violence Association cites that children of domestic violence are six times more likely to commit suicide, 50% more likely to abuse drugs and alcohol, 74% more likely to commit a violent crime and three times more likely to repeat the cycle of abuse in adulthood.

Town Clock CDC – 1 of 40 in US

Town Clock Community Development Corporation is a nonprofit, 501(c)3 organization. Town Clock CDC’s facility (Dina’s Dwellings) opened in April 2016 after the sanctuary of the 200-year-old First Reformed Church of New Brunswick was transformed into 10 long-term affordable housing units with supportive services for survivors. In October 2020, Town Clock CDC expanded its facility by transforming the church’s sexton house into a home for a mother and up to five children. This housing model is one of only 40 establishments of its kind in the entire United States, and remains the largest, permanent housing program for survivors of domestic violence and their children in New Jersey. In 2019, Town Clock CDC launched the Being Brave Event & Award.

Being Brave Event & Award

Being Brave 2020 will be a virtual celebration of the enduring and creative strength of survivors who are rebuilding their lives after domestic violence. This uplifting and inspirational broadcast will take place on Thursday, October 22, 2020, at 7:30 PM. Full press release.

Share article on social media or email:

Chai Launches First Saliva-Based COVID-19 Surveillance Test Kit To Help Schools And Businesses Reopen Safely


News Image

The COVID-19 saliva-based Surveillance Kit uses PCR to deliver highly sensitive results in 90 minutes.

Chai, an innovative biotechnology tools provider with a mission to expand the use and applications of molecular testing, announced today that they are releasing the first saliva-based, pooled COVID-19 surveillance test kit to detect nucleic acid from the SARS-CoV-2 virus. The test kit is designed to run on the Open qPCR platform and other compatible RT-qPCR instruments. The COVID-19 Surveillance Test Kit delivers results in 90 minutes on an easy-to-use, highly portable instrument. Testing can be performed outside of lab and healthcare environments, broadening COVID-19 detection efforts across businesses, schools, and industrial facilities.

The test kit is intended for surveillance use, where groups of people can be tested to make population-level decisions. Surveillance examples include monitoring closed groups in frequent contact with one another such as classroom cohorts, work shifts, or nursing wards. The surveillance pooled testing format prevents non-specific results from being obtained, which allows the test kit to be run outside of lab and healthcare settings. Pooling also enables processing of up to 5 individuals per sample, or up to 70 individuals per run, which greatly increases testing capacity and conserves testing resources in short supply.

Because it is saliva-based, the COVID-19 Surveillance Test Kit does not require collection with an invasive nasopharyngeal swab. Samples can be reliably self-collected, minimizing the risk of others being exposed to the virus. The ease of saliva collection is key to enabling the widespread, routine testing proposed by experts to contain the COVID-19 pandemic.

“People should not have to choose between speed and accuracy. The COVID-19 Surveillance Test Kit uses the CDC-recommended, gold-standard detection method of RT-qPCR to deliver highly sensitive results in 90 minutes so that immediate action can be taken if an infection is detected. The saliva-based, simple workflow make it easier for schools and business owners to test routinely. This test kit will make a meaningful difference in our nation’s ability to slow the spread of COVID,” said Josh Perfetto, CEO of Chai.

The Surveillance Test Kit complements Chai’s Coronavirus Environmental Surface Test Kit, which detects SARS-CoV-2 on high-touch surfaces such as door handles, keyboards, and phones. Environmental surface testing is especially useful in areas exposed to the public, where testing people individually is not practical.

About Chai

Chai is a biotechnology company based in Santa Clara, CA focused on bringing molecular PCR-testing to a wide range of environments, from research labs to non-traditional biotechnology settings. Their core molecular technologies have applications in diverse fields and environments, such as breweries, water quality labs, and food facilities. The Open qPCR, their flagship Real-Time PCR machine, is used by the world’s top biomedical universities and can be found in over 60 countries and counting. Chai’s commitment to making molecular testing accessible is evidenced by their open platform, open source, and license-free reagents philosophy.

Learn more about the test kit at https://www.chaibio.com/covid-19-surveillance-testing. Additional information about Chai’s innovative solutions can be found at http://www.chaibio.com.

Share article on social media or email:

Gallaudet University Receives $800,000 From Mellon Foundation to Advance Education Equity for Deaf Students Through Visual Teaching and Learning Innovation


News Image

With Mellon’s support, Gallaudet now has the opportunity to establish an innovative, global 21st century model for visual learning and help create greater access, inclusion, and equity for deaf students.

Gallaudet University announced today that it has been awarded an $800,000 grant by The Andrew W. Mellon Foundation to advance visual-centric teaching and learning for deaf students worldwide.

The three-year grant will allow Gallaudet to create a new worldwide model for improving the overall quality of teaching and learning for deaf students and other students who learn best visually. Gallaudet will use the Mellon grant to develop an innovative digital pedagogy that is visually centered, grounded in American Sign Language (ASL) and English bilingualism, and culturally responsive.

In 1864, President Abraham Lincoln signed Gallaudet’s charter with the unique purpose of providing visually accessible higher education. Today, Gallaudet remains the only university in the world providing deaf and hard of hearing students with a bilingual education in ASL and English.

“Gallaudet is honored to have been awarded this important grant by The Andrew W. Mellon Foundation,” said Roberta J. Cordano, president of Gallaudet University. “Deaf people live and learn through a visually-based language, yet the majority of classrooms are largely based on spoken language, even in today’s new era of remote learning. With Mellon’s support, Gallaudet now has the opportunity to establish an innovative, global 21st century model for visual learning and help create greater access, inclusion, and equity for deaf students.”

Gallaudet’s grant project will address several key areas of teaching and learning, including access to visual-centric bilingualism; culturally responsive and trauma-informed education; and

digitally adaptive learning matched to the strengths and needs of visual learners. The trauma-informed education model, for example, will address interactive and visual approaches to conflicts and issues using interactive theater.

Key expected outcomes and benefits of the Visual-Centric Teaching and Learning project, include:

  • redesigning campus-wide professional development curriculum to integrate visual-centric, ASL and English bilingual, culturally responsive, and trauma-informed pedagogy;
  • establishing faculty mentors and coaches to implement the pedagogy;
  • redesigning of teaching strategies and course content to establish multiple approaches to address important social issues, including racism, sexism, economic injustice and audism;
  • training for faculty and staff with Bilingual Approaches and Multicultural Curriculum Transformation seminars;
  • redesigning of more than 100 courses for the visual-centric, bilingual, culturally responsive, and trauma-informed pedagogy; and
  • establishing an extensive digital video library of exemplary best practices.

A key goal of the Visual-Centric Teaching and Learning project is to address ongoing social inequities deaf students and other linguistically diverse learners continue to face. According to Gallaudet University, inadequate access to visual language and learning remains a critical societal issue. Additionally, more than 90 percent of deaf and hard of hearing children are born to hearing parents where spoken language, not American Sign Language, is used at home. Even when families choose to learn ASL, young students who are deaf and hard of hearing are usually not educated in ASL and English bilingual learning environments. These and other factors result in deaf students continuing to be underrepresented in higher education.

Gallaudet University, federally chartered in 1864, is a bilingual, diverse, multicultural institution of higher education that ensures the intellectual and professional advancement of deaf, hard of hearing and deafblind individuals through American Sign Language and English. The university enrolls over 1,300 students in more than 40 undergraduate majors, as well as many graduate programs at the master’s and doctoral level. It also conducts much research in a variety of fields, including brain imaging, educational neuroscience, education, linguistics, psychology, Deaf history and culture, and Black Deaf history and culture.

Media contacts

The Durkin Agency

Alana Cowan

alanacowan5@gmail.com

Gallaudet University

Robert Weinstock

robert.weinstock@gallaudet.edu

Share article on social media or email:

Biocatalytic Cascades – Challenges and Opportunities, Upcoming Webinar Hosted by Xtalks


Participants will gain insight into the strengths and weaknesses of each approach by comparing/contrasting past accomplishments and challenges, and explore future opportunities and design strategies for advanced chemical processes driven by biocatalytic reaction cascades.

Biocatalytic cascades involving two or more enzymes hold the promise to facilitate complex, multi-step chemical transformation in efficient and sustainable ways. In vivo cascades are assembled by metabolic engineering and have a well-established track-record from the bench to large-scale fermentation. In contrast, in vitro cascades have recently breached proof-of-concept in the test tube by successfully demonstrating their scalability for industrial production of high-value compounds, such as the anti-retroviral drug islatravir, and the low-calorie rare sugar tagatose.

In this free webinar, participants will gain insight into the strengths and weaknesses of each approach by comparing/contrasting past accomplishments and challenges, and explore future opportunities and design strategies for advanced chemical processes driven by biocatalytic reaction cascades. The panel of speakers consists of experts in the field of synthetic biology, each an architect and practitioner of biocatalytic cascades.

Join Jeff Moore, Principal Scientist, Merck & Co, Nick Turner, Professor of Chemical Biology, University of Manchester, Dan Wichelecki, Co-Founder, Chief Scientific Officer, Bonumose LLC and Michelle Chang, Professor, Departments of Chemistry, Molecular and Cell Biology and Chemical and Biomolecular Engineering, UC Berkeley and moderated by Stefan Lutz, Senior Vice President, Research , Codexis in a live webinar on Tuesday, October 27, 2020 at 10am EDT (2pm GMT/UK).

For more information or to register for this event, visit Biocatalytic Cascades – Challenges and Opportunities.

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com

For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Share article on social media or email:

ANY LAB TEST NOW Celebrates Highest-Ever Franchise Times Ranking


News Image

Our highest-ever ranking in Franchise Times’ Top 200+ is something worth celebrating amid an unprecedented year in so many ways. It’s an outstanding achievement, and we are proud of the hard work all of our staff and franchisees have put in this year.

For the fourth consecutive year, ANY LAB TEST NOW® has landed a spot on the Franchise Times Top 200+ list, one of the world’s most admired franchise system rankings. ANY LAB TEST NOW is ranked #409 on this year’s distinguished list. Recognized by entrepreneurs and franchisors as a top competitive tool of measurement, the Franchise Times Top 200+ list recognizes ANY LAB TEST NOW for the exceptional performance in systemwide sales and growth.

“Our highest-ever ranking in Franchise Times’ Top 200+ is something worth celebrating amid an unprecedented year in so many ways. It’s an outstanding achievement, and we are proud of the hard work all of our staff and franchisees have put in this year,” says Clarissa Bradstock, CEO of ANY LAB TEST NOW. “After the initial hit that all businesses experienced when COVID arrived, we bounced back quickly, and have continued to experience growth, proving that ANY LAB TEST NOW is what you could term a “COVID-resistant” business model,” Bradstock adds.

ANY LAB TEST NOW currently has 188 locations across the country, and the direct access lab testing company is a consistent leader in the retail healthcare industry. “The ANY LAB TEST NOW business model stands out this year to entrepreneurs because it is has shown to be a model that will grow and thrive in the ever-changing world, with a well-developed product and a continued success rate even during a pandemic,” says Terri McCulloch, Vice President of Business Development of ANY LAB TEST NOW. “We are finding our COVID-resistant model to be extremely appealing for an array of reasons, including future viability, low startup costs and the long-term strategies mapped out to maintain the continued success we’ve been seeing,” McCulloch explains. “ANY LAB TEST NOW offers franchisees multiple diverse sales opportunities, from direct-to-consumer to businesses and even government entities. We provide consumers the power to take control of their own health, which more important today than it ever has been with the emergence of the pandemic this year and the established healthcare trends like higher out-of-pocket expenses associated with high-deductible insurance.”

The Franchise Times Top 200+ is an annual ranking of the 500 largest franchise systems in the United States by global systemwide sales. In a five-month research process, and building upon a database that began in 1999, companies are evaluated using a combination of voluntary reports and publicly available data. ANY LAB TEST NOW’s position on the ranking is a testament to its strength as a franchise opportunity.

About ANY LAB TEST NOW®

Founded in 1992, ANY LAB TEST NOW is a franchise direct access lab testing company that provides thousands of standard lab tests to consumers and businesses in a professional, convenient and cost-effective, transparent manner with almost 190 franchises around the U.S., ANY LAB TEST NOW offers a variety of affordable and confidential lab tests to consumers and businesses including general health and wellness panels, pregnancy, HIV/STD, drug, paternity and many more tests. To learn more about ANY LAB TEST NOW, visit http://www.anylabtestnow.com or like us on Facebook, http://www.facebook.com/anylabtestnowcorp.

Share article on social media or email:

SMP Nutra Donates 1,000 Vitamin D3 Bottles in New York for COVID Relief


Donating Vitamin D Bottles to our local community!

This is really the first time we are actually, during covid giving out vitamins. It’s so important now you can’t even pay for food, how are you going to pay for vitamins? Thank you Gentlemen for your donation!

SMP Nutra understands that the current climate of COVID has made life much harder for most regular people.

Many people do not know where their next meal is coming from. Let alone keeping up with proper daily vitamin & mineral intake.

That is why we manufactured 1,000 Vitamin D3 bottles with the sole purpose of donating to our local community.

Each Vitamin D3 bottles contains a 60-day supply of Vitamin D3 (5000 IU) & Olive Oil.

We donated boxes of bottles to Long Island Cares, Central Islip Civic Center, and directly to people in our local community.

“This is really the first time we are actually, during COVID giving out vitamins. It’s so important now you can’t even pay for food, how are you going to pay for vitamins? Thank you, Gentlemen for your donation!” – Joan Crescitelli – Executive Director – Central Islip Civic Council

“This is wonderful, thank you so much!” – Paule Pachter – Chief Executive Officer at Long Island Cares, Inc.

As a supplement manufacturer, we handle manufacturing hundreds of thousands of vitamin bottles per month.

With the emergence of COVID, we have experienced a massive surge in demand for manufacturing vitamins & supplements.

We decided we need to give back to our community, who has been more negatively affected by the effects of COVID.

It felt great giving back, and we look forward to continued vitamin donations in the future!

Share article on social media or email:

Danger of Fatalities Among Individuals with IDD Can Be Decreased with New Tools, Education


Screening individuals with IDD early to determine risks to their health is essential for avoiding these risks and helping people with IDD live longer, healthier lives.

Even without the pandemic, people who live with IDD are at higher risk of mortality for a variety of reasons. Early identification of possible risk factors is the key to finding preventative actions.

Up to 4% of the United States population, or 7 to 8 million Americans, live with an intellectual or developmental disability (IDD)(1). The degree of mortality risk to a specific person can be measured in health care levels (HCLs), which, along with age, is important prognostically according to information gathered in the Georgia Department of Behavioral Health and Developmental Disabilities 2019 Annual Mortality Report; for every one-unit increase in HCL, there is a 75% increase in the odds of dying(2). Methods to predict such risk are essential for taking actionable steps to avoid harm and prevent death, according to Health Risk Screening, Inc. (HRS).

The Georgia Annual Mortality Report found a significant increase in mortality in 2019 among people living with IDD. People with higher HCLs were found to have a group mortality rate exceeding that of the overall population mortality rate(2). But these findings don’t take the current pandemic into account. Other research shows that people living with IDD are more likely to contract COVID-19(3). And if they do develop an infection, these same individuals are 2-2.5 times more likely to die from the disease compared to individuals without IDD.(3)

Dr. Craig Escudé, President of HRS, says, “Even without the pandemic, people who live with IDD are at higher risk of mortality for a variety of reasons. Early identification of possible risk factors is the key to finding preventative actions that will help these people live longer with a better quality of life.”

Doctors often point to the “fatal five” when discussing the most common causes of death among people living with IDD—these include aspiration, bowel obstruction, dehydration, seizures, and sepsis/infections.(4) Unlike the top causes of death in the U.S., such as heart disease or cancer(5), these five conditions are more easily prevented. Additionally, individuals with IDD are more likely to have comorbid medical conditions which increase mortality risk, such as obesity, diabetes, heart disease, and smoking-related maladies.(6)

HRS’s Health Risk Screening Tool (HRST) helps doctors, caregivers, and others measure various health risks associated with IDD which may prevent individuals from engaging in functional activities(7). Numerical ratings are calculated using a 22-item scale to discover an individual’s overall HCL. The higher the HCL, the more at risk the person is for events which may lead to death. However, the HRST doesn’t just identify a person’s risk level—it also provides actionable steps that can be used to guide treatment(7).

For the seventh year running, the GA 2019 Annual Mortality Report found that the HRST accurately predicts mortality in individuals with IDD(2). 26 states(7), including Pennsylvania, Illinois, Kentucky, Maryland, and Missouri, have already started using the tool to detect health risks earlier for people living with IDD.

Escudé says, “Since the HRST predicts mortality, clinicians and other caregivers can use it to establish a person’s health care needs and determine the level of health care that’s appropriate. These actions serve as the basis for the development of a comprehensive plan of care that helps negate these risks.”

Screening individuals with IDD early to determine risks to their health is essential for avoiding these risks and helping people with IDD live longer, healthier lives. To help providers, including non-IDD specialized physicians, and others learn more about the HRST and its predictiveness of mortality, HRS, Inc. will hold a news conference Wednesday, November 4, 2020, at 11:30 am EST. The event is intended to introduce the HRST, review the research that validates the tool, and answer any questions about screening individuals with IDD for specific health risks. You can register for the free news conference by clicking here, or visiting https://attendee.gotowebinar.com/register/3637507031700978443?source=PR.

About Health Risk Screening, Inc.:

Health Risk Screening, Inc.’s roots began in 1992. HRS is an industry leader in training courses, webinars, and materials to help at-risk populations. HRS’s focus is on developing tools and training for the person-centered support of these vulnerable populations. Through the education of government agencies and service providers, HRS aims to improve lives. One such tool is the Health Risk Screening Tool, of which HRS is the sole developer, producer, and distributor. The web-based HRST is the most widely used and validated health risk screening instrument for people with intellectual and developmental disabilities. With unrelenting focus, HRS works to fulfill its mission of improving the health and quality of life for people faced with these types of vulnerabilities. For more information, visit http://www.hrstonline.com.

Sources

1.    empower-wny.org/wp-content/uploads/2016/08/Fact-Sheet-final3.pdf.

2.    “Mortality Reports.” Georgia Department of Behavioral Health and Developmental Disabilities, 2020, dbhdd.georgia.gov/organization/be-informed/reports-performance/mortality-reports.

3.    Shapiro, Joseph. “COVID-19 Infections And Deaths Are Higher Among Those With Intellectual Disabilities.” NPR, NPR, 9 June 2020, npr.org/2020/06/09/872401607/covid-19-infections-and-deaths-are-higher-among-those-with-intellectual-disabili.

4.    “Fatal Five, The Fatal Four Developmental Disabilities.” HRS Inc, 5 Oct. 2020, hrstonline.com/hrsu/the-fatal-five-fundamentals/.

5.    “FastStats – Leading Causes of Death.” Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, 6 Feb. 2020, cdc.gov/nchs/fastats/leading-causes-of-death.htm.

6.    “Disability Impacts All of Us Infographic.” Centers for Disease Control and Prevention, Centers for Disease Control and Prevention, 16 Sept. 2020, cdc.gov/ncbddd/disabilityandhealth/infographic-disability-impacts-all.html.

7.    “Health Risk Screening Tool, Health Risk Assessment Tool.” HRS Inc, 22 Sept. 2020, hrstonline.com/health-risk-screening-tool/.

Share article on social media or email:

CHI’s 28th Molecular Med Tri-Conference Shifts to Virtual Event


We are inspired by the response of the precision medicine community — their eagerness to share their expertise while practicing social distancing, and by their commitment to furthering the biopharmaceutical research and developments needed to advance medical science and improve lives

Over the past 27 years, Molecular Medicine Tri-Conference has served as the leading international meeting place for the precision medicine community. In 2021, TRI-CON attendees will join over 3,000 international thought leaders to discuss the latest research and technologies in COVID-19 diagnostics and vaccines, point-of-care diagnostics, biomarkers and liquid biopsy, data analytics and artificial intelligence, and immuno-oncology and cell therapy. In addition to the leading research and technology presentations you have come to expect at the Tri-Con, we have added structured networking opportunities and the free technology Expo, for a comprehensive 3-day program designed to maximize collaboration and innovation.

“Cambridge Healthtech Institute once again takes the leadership role of bringing together the life science community at the Virtual Conference & Expo 2021,” said Julia Boguslavsky, Executive Conference Director of Tri-Con. “We are inspired by the response of the precision medicine community — their eagerness to share their expertise while practicing social distancing, and by their commitment to furthering the biopharmaceutical research and developments needed to advance medical science and improve lives.”

Molecular Med Tri-Conference is taking place virtually February 16-18, 2021. To view event programs, distinguished speakers, and networking opportunities please visit http://www.TriConference.com.

Cambridge Healthtech Institute (CHI) is the preeminent life science network for leading researchers and business experts from top pharmaceutical, biotech and academic organizations. CHI’s portfolio of products includes Cambridge Healthtech Institute Conferences, Insight Pharma Reports, Barnett International, Cambridge Meeting Planners and Healthtech Publishing, which includes Bio-IT World, Clinical Informatics News and Diagnostics World.

Share article on social media or email: